AI-Driven Pharmaceutics Company Helixon Raise CNY 500 Mn (USD $74.35 Million) in Series A Round

6/22/2022

Written by

EqualOcean -- As one of the key players in computational biology, Helixon received recognition from the capital market for its innovation in machine learning algorithms and data acquisition technologies which reconstruct the drug development process and improve the efficiency of new drug development. The founder of Helixon is Jian Peng ... Associate Professor of Computer Science at the University of Illinois Urbana-Champaign and the Distinguished Visiting Scholar of Institute of AI Industry Research, Tsinghua University.

Read the article.


Share this story

This story was published June 22, 2022.